Ionis Pharmaceuticals EVP sells $194,939 in stock
Patrick R. O'Neil, Executive Vice President, Chief Legal Officer & General Counsel of Ionis Pharmaceuticals Inc. (NASDAQ:IONS), recently sold 6,165 shares of the company's common stock. The shares ...
KALW5h
Spinal stimulation restored muscles wasted by rare genetic disorder
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...
American Association of Individual Investors6h
Which Is a Better Investment, Biogen Inc. or Neurocrine Biosciences, Inc. Stock?
Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
18yo Malaysian climbs Mount Kinabalu to raise funds for brother with disability
Jaden Lim hopes to raise awareness of spinal muscular atrophy and get sponsors to donate RM10 per km of his climb for his brother.
clinicaltrialsarena17h
Medtronic SCS device restores function in SMA trial
The first-in-human SCS trial saw all three SMA patients able to increase their walking distance within six minutes to 20 meters.
Hosted on MSN21h
A spine-zapping implant helped 3 people with a muscle-wasting disease walk better
Three people with a muscle-destroying disease destined to worsen got a little stronger — able to stand and walk more easily — ...